drugset / Trial / NCT01080625

Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver Transplantation

NCT01080625

Completed 96 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

Postreperfusion syndrome (PRS) is a relatively common phenomenon in patients undergoing liver transplantation which is characterized by an acute drop in blood pressure immediately after the prefusion is restored to the transplanted liver. We hypothesized that PRS would be prevented when phenylephrine or epinephrine is administered immediately prior to reperfusion in liver transplantation.

Timeline

Start
2010-04
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 10 ug Intravenous
Subject Phenylephrine Small molecule 100 ug

Indications

No indication recorded.